ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors)

  1. Winthrop, K.L.
  2. Mariette, X.
  3. Silva, J.T.
  4. Benamu, E.
  5. Calabrese, L.H.
  6. Dumusc, A.
  7. Smolen, J.S.
  8. Aguado, J.M.
  9. Fernández-Ruiz, M.
Journal:
Clinical Microbiology and Infection

ISSN: 1469-0691,  1198-743X

Year of publication: 2018

Volume: 24

Pages: S21-S40

Type: Review

DOI: 10.1016/J.CMI.2018.02.002 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus